. Erratum: Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth J Clin Oncol 2023 Dec 19:JCO2302620. doi: 10.1200/JCO.23.02620.
PMID: 38113406